Browsing Pharmacy Research by Author "Alam, Mohammed Fasihul"
Now showing items 1-3 of 3
-
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
Al-Ziftawi, Nour Hisham; Alam, Mohammed Fasihul; Elazzazy, Shereen; Shafie, Asrul Akmal; Hamad, Anas; Mohamed Ibrahim, Mohamed Izham... more authors ... less authors ( MDPI , 2022 , Article)Palbociclib and ribociclib are indicated in the first-line treatment of hormonal-receptor-positive HER-2 negative (HR+/HER-2 negative) advanced breast cancer. Despite their clinical benefit, they can increase healthcare ... -
The Economic Impact of Optimizing a COVID-19 Management Protocol in Pre-Existing Cardiovascular Disease Patients
Dina, Abushanab; Eldebs, Mohammed; Basha, Ahmed; Naseralallah, Lina; Kazkaz, Hadia; Moursi, Ahmed; Albazoon, Fatima; Wafi, Omar; Badran, Saif; Doi, Suhail A.R.; Al-Maadeed, Somaya; Alam, Mohammed Fasihul; Al-Badriyeh, Daoud... more authors ... less authors ( Elsevier , 2022 , Article)This study answers the question of whether the health care costs of managing COVID-19 in preexisting cardiovascular diseases (CVD) patients increased or decreased as a consequence of evidence-based efforts to optimize the ... -
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study.
Mohammedain, Shahd A; Badran, Saif; Elzouki, AbdelNaser Y; Salim, Halla; Chalaby, Ayesha; Siddiqui, Mya; Hussein, Yehia Y; Rahim, Hanan Abdul; Thalib, Lukman; Alam, Mohammed Fasihul; Al-Badriyeh, Daoud; Al-Maadeed, Sumaya; Doi, Suhail Ar... more authors ... less authors ( Future Medicine , 2023 , Article)This study aims to perform an external validation of a recently developed prognostic model for early prediction of the risk of progression to severe COVID-19. Patients were recruited at their initial diagnosis at two ...